BRIEF published on 12/02/2024 at 15:14, 1 year 9 months ago The Vanguard Group Reports Stake in Direct Line Insurance Group Investment Stake Disclosure Vanguard Insurance Sector Direct Line
BRIEF published on 12/02/2024 at 15:14, 1 year 9 months ago Le groupe Vanguard annonce une participation dans Direct Line Insurance Group Investissement Avant-garde Secteur Des Assurances Divulgation Des Enjeux Ligne Directe
PRESS RELEASE published on 12/02/2024 at 15:09, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.45% interest in Direct Line Insurance Group plc, with 71,503,989 ordinary shares owned. Additional disclosure made for Aviva plc Relevant Securities The Vanguard Group Ownership Disclosure Direct Line Insurance Group Plc Aviva Plc
BRIEF published on 11/29/2024 at 15:10, 1 year 9 months ago Vanguard Group Discloses Stake in Direct Line Insurance Takeover Code Vanguard Group Stake Disclosure Financial Markets Direct Line Insurance
BRIEF published on 11/29/2024 at 15:10, 1 year 9 months ago Le groupe Vanguard dévoile sa participation dans Direct Line Insurance Marchés Financiers Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Assurance Ligne Directe
PRESS RELEASE published on 11/29/2024 at 15:05, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.45% stake in Direct Line Insurance Group plc per Form 8.3 filing Form 8.3 Disclosure Financial Filing Vanguard Group Direct Line Insurance
BRIEF published on 03/25/2024 at 15:31, 2 years 5 months ago The Vanguard Group Reports Ownership in Direct Line Insurance Group plc The Vanguard Group Takeover Code Ownership Disclosure Direct Line Insurance Investment Transparency
BRIEF published on 03/25/2024 at 15:31, 2 years 5 months ago The Vanguard Group annonce sa participation dans Direct Line Insurance Group plc Le Groupe Vanguard Code De Reprise Divulgation De Propriété Assurance En Ligne Directe Transparence Des Investissements
PRESS RELEASE published on 03/25/2024 at 15:26, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.00% interest in Direct Line Insurance Group plc. Purchase of 12,040 Ordinary 10 10/11p shares at 2.09 GBP per unit Form 8.3 The Vanguard Group Inc. Securities Disclosure Stock Purchase Direct Line Insurance Group Plc
BRIEF published on 03/22/2024 at 15:31, 2 years 5 months ago The Vanguard Group Announces 5% Stake in Direct Line Insurance Group PLC Investment The Vanguard Group Financial Disclosure Insurance Sector Direct Line Insurance
Published on 09/11/2026 at 04:00, 5 hours 44 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 19 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 24 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 44 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 24 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 39 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 44 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 44 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 44 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 44 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 14 minutes ago Availability of the 2026 Interim Financial Report
